Cometriq for Thyroid Cancer User Reviews
- Rav...
- Taken for 1 to 6 months
- November 6, 2018
"'This drug is not good.' My father was on 60 mg Cabozantinib for about 5 weeks with a lot of side effects. His BP is normal, but fatigue is still there, and he can't walk without support. His hands, feet, and whole body were numb. He can't walk more than 10 steps. Also, every day before or after taking food, he is vomiting, which is still continuing. His weight before we started Cometriq (Cabozantinib) was 52.5 kg, and now his weight is 45 kg. Today I decided to stop this medicine. So expensive for a medicine that does nothing. The best way to earn money is to play with people's emotions. This method is not good for the patient and the patient's family."
Are you taking this medicine?
Your review helps others make informed decisions.More about Cometriq (cabozantinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
"I felt miserable from the start of taking this medicine. It did more harm than good. I experienced severe diarrhea (watery and explosive). I experienced nausea at any given time of the day. I developed painful sores on the palm of my hands and on my ankles. It became difficult to brush my teeth, turn a doorknob, and even wash my hands. Any use of my hands was painful."